Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Non-Current Assets (2016 - 2020)

Historic Non-Current Assets for Monopar Therapeutics (MNPR) over the last 5 years, with Q3 2020 value amounting to $68858.0.

  • Monopar Therapeutics' Non-Current Assets changed N/A to $68858.0 in Q3 2020 from the same period last year, while for Sep 2020 it was $386670.0, marking a year-over-year increase of 48826.12%. This contributed to the annual value of $122381.0 for FY2019, which is 8618.46% up from last year.
  • Latest data reveals that Monopar Therapeutics reported Non-Current Assets of $68858.0 as of Q3 2020.
  • In the past 5 years, Monopar Therapeutics' Non-Current Assets registered a high of $800393.0 during Q4 2016, and its lowest value of $65731.0 during Q4 2018.
  • In the last 5 years, Monopar Therapeutics' Non-Current Assets had a median value of $122381.0 in 2019 and averaged $405876.3.
  • Per our database at Business Quant, Monopar Therapeutics' Non-Current Assets crashed by 9178.39% in 2018 and then soared by 8618.46% in 2019.
  • Over the past 5 years, Monopar Therapeutics' Non-Current Assets (Quarter) stood at $800393.0 in 2016, then decreased by 0.05% to $800031.0 in 2017, then tumbled by 91.78% to $65731.0 in 2018, then surged by 86.18% to $122381.0 in 2019, then crashed by 43.73% to $68858.0 in 2020.
  • Its Non-Current Assets was $68858.0 in Q3 2020, compared to $73050.0 in Q2 2020 and $122381.0 in Q1 2020.